Compare BRAG & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRAG | ABVC |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.8M | 68.7M |
| IPO Year | N/A | N/A |
| Metric | BRAG | ABVC |
|---|---|---|
| Price | $2.21 | $2.69 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 78.4K | 60.0K |
| Earning Date | 11-13-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $123,839,024.00 | $797,916.00 |
| Revenue This Year | $6.62 | $735.18 |
| Revenue Next Year | $5.85 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 7.49 | ★ 56.52 |
| 52 Week Low | $1.96 | $0.40 |
| 52 Week High | $6.12 | $5.48 |
| Indicator | BRAG | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 44.79 |
| Support Level | $2.07 | $2.45 |
| Resistance Level | $2.21 | $3.06 |
| Average True Range (ATR) | 0.16 | 0.18 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 35.85 | 39.34 |
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, the United States, Croatia, and other regions.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.